Ellen Zane

Insider profile

Currently holds positions in PAREXEL International Corp, Azenta Inc, Boston Scientific Corp and Haemonetics Corp

Positions

Position Company Period
Independent Director PAREXEL International Corp July 26, 2006 -
Independent Director Azenta Inc May 9, 2012 -
Independent Director Boston Scientific Corp April 15, 2016 -
Independent Director Haemonetics Corp Jan. 1, 2018 -
Independent Director Haemonetics Corp July 27, 2012 - April 10, 2016
Independent Director Lincare Holdings Inc Sept. 16, 2010 - Aug. 8, 2012

Ellen Zane's trades of Boston Scientific Corp's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
396.46
Quantity 13,510
Value US$4,946,429
Transaction date
Planned sale
Price
285.86
Quantity 68,265 -49.2%
Value US$3,621,137
Transaction date
Proposed sale
Price
333.86
Quantity 2,330
Value US$4,263,508
Transaction date
Planned sale
Price
102.24
Quantity 2,901 -10.7%
Value US$296,599
Transaction date
Planned sale
Price
101.13
Quantity 9,990 -27.0%
Value US$1,010,301
Transaction date
Proposed sale
Price
100.91
Quantity 9,990
Value US$1,008,081
Transaction date
Proposed sale
Price
104.23
Quantity 13,586
Value US$1,416,088
Transaction date
Planned sale
Price
104.23
Quantity 13,586 -28.0%
Value US$1,416,134
Transaction date
Proposed sale
Price
55.78
Quantity 18,766
Value US$1,046,697
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-11-06 2025-11-06 PrS Proposed sale
13,510
396.46
US$4,946,429
13,510 396.46 US$4,946,429
2025-11-06 2025-11-06 PlS Planned sale
68,265 -49.2%
285.86
US$3,621,137
68,265 -49.2% 285.86 US$3,621,137
2025-10-28 2025-10-28 PrS Proposed sale
2,330
333.86
US$4,263,508
2,330 333.86 US$4,263,508
2025-10-28 2025-10-28 PlS Planned sale
2,901 -10.7%
102.24
US$296,599
2,901 -10.7% 102.24 US$296,599
2025-10-28 2025-10-27 PlS Planned sale
9,990 -27.0%
101.13
US$1,010,301
9,990 -27.0% 101.13 US$1,010,301
2025-10-27 2025-10-27 PrS Proposed sale
9,990
100.91
US$1,008,081
9,990 100.91 US$1,008,081
2025-02-24 2025-02-24 PrS Proposed sale
13,586
104.23
US$1,416,088
13,586 104.23 US$1,416,088
2025-02-24 2025-02-24 PlS Planned sale
13,586 -28.0%
104.23
US$1,416,134
13,586 -28.0% 104.23 US$1,416,134
2023-08-09 2023-08-09 PrS Proposed sale
18,766
55.78
US$1,046,697
18,766 55.78 US$1,046,697